+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Colon Cancer Drugs Market Research Reports

Colorectal Cancer: Update Bulletin #1 - Product Thumbnail Image

Colorectal Cancer: Update Bulletin #1

  • Newsletter
  • August 2021
From
From
From
From
From
From
From
Disease Analysis: Colorectal Cancer - Product Thumbnail Image

Disease Analysis: Colorectal Cancer

  • Report
  • May 2021
  • 88 pages
From
From
From
From
From
From
From
Anal Cancer - Pipeline Insight, 2021 - Product Thumbnail Image

Anal Cancer - Pipeline Insight, 2021

  • Clinical Trials
  • March 2021
  • 60 pages
From
From
Loading Indicator

Colon (or colorectal/bowel cancer) is diagnosed in over 1 million people annually, and accounts for over 0.5 million deaths each year. According to a recent article in the renowned Lancet medical journal, in Europe the 5-year survival for colorectal cancer is less than 60% so there is certainly considerable market potential for effective and accessible new pharmaceutical drugs. Reports in the Colon Cancer Section will help industry operators, and those considering entering this market, to answer the key questions such as what are the latest clinical trials, what are the R&D trends, what is the potential for personalized medicine, where are the opportunities in major markets such as China and the US, etc. Show Less Read more

adroll